Applicable from 1.1.2021 in accordance with forskrift om legemidler (FOR 2009-12-18 nr 1839) § 15-3. The fee rates have been adjusted by 2.6% from 1.1.2021 in line with the state budget.

 

The fees are in Norwegian kroner (NOK).

 

For Marketing Authorisation Applications (MAA) in Decentralised (DCP) and Mutual Recognition procedure (MRP) a fee, at time of agreement for Norway to be RMS, has been introduced. If the application subsequently is withdrawn, this fee will not be reimbursed.

For grouped variations, according to Variation Regulation EC 1234/2008, the fee will be equal to the sum of each variation applicable for a fee.

 

For products intended for MUMS (Minor Use/Minor Species) there is a 50 % reduction in the fee. MUMS-status must be clarified with the Norwegian Medicines Agency before submission.

 

The Norwegian Medicines Agency will invoice the fee on the basis of received application. Please note that we invoice the company that submits the application, should no other receiver be stated in the cover letter. Reference, such as PO-number, must be stated in the cover letter. Payment is due at the latest within 30 days from date of invoice.

 

In specific cases the Norwegian medicines Agency may waive the required fee.